Vaccines have saved more lives than any other medical advance in recent history and childhood vaccination continues to save up to 3 million lives every year. Yet, millions of people in low- and middle-income countries are suffering and dying from infectious diseases such as tuberculosis, malaria, yellow fever and HIV. Many of these diseases are challenging from the scientific and business perspectives, with few or no market incentives to encourage R&D, requiring academia, non-profit organizations, industry and philanthropy to develop new approaches and partnerships to combat these diseases.

The panelists will discuss how to galvanize the development of medicines to treat, control and eliminate major infectious diseases of low- and middle-income countries, several of which are poised to spread to high-income countries. Participants will learn about new technologies and partnerships meant to overcome scientific and resource barriers to help bring these much needed products to the market.

Session ID: 36184